Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Biorxiv : the Preprint Server for Biology
|
June 6, 2025
GCN5L1 inhibits pyruvate dehydrogenase phosphorylation during cardiac ischemia-reperfusion injury
Paramesha Bugga, Michael W Stoner, Janet R Manning, et al.
Life Sciences
|
August 7, 2022
Empagliflozin prohibits high-fructose diet-induced cardiac dysfunction in rats via attenuation of mitochondria-driven oxidative stress
Paramesha Bugga, Soheb Anwar Mohammed, Md Jahangir Alam, et al.
Current Research in Physiology
|
February 7, 2022
Diet-induced obese mice are resistant to improvements in cardiac function resulting from short-term adropin treatment
Dharendra Thapa, Bingxian Xie, Bellina A S Mushala, et al.
The Biochemical Journal
|
April 29, 2024
Validation of GCN5L1/BLOC1S1/BLOS1 antibodies using knockout cells and tissue
Paramesha Bugga, Michael W Stoner, Janet R Manning, et al.
Scientific Reports
|
April 15, 2023
G-protein coupled receptor 19 (GPR19) knockout mice display sex-dependent metabolic dysfunction
Bellina A S Mushala, Bingxian Xie, Ian J Sipula, et al.
Biorxiv : the Preprint Server for Biology
|
November 19, 2025
Essential Role for Trf2 in Cardiac Development and Function
Ali Hakim Shoushtari, Aysenur Danis, Michael Wayne Stoner, et al.
FASEB Bioadvances
|
July 6, 2026
Essential Role for Telomeric Repeat-Binding Factor 2 in Cardiac Development and Function
Ali Hakim Shoushtari, Aysenure Danis, Michael Wayne Stoner, et al.
Physiological Reports
|
August 4, 2022
GCN5L1 impairs diastolic function in mice exposed to a high fat diet by restricting cardiac pyruvate oxidation
Dharendra Thapa, Paramesha Bugga, Bellina A S Mushala, et al.
Biorxiv : the Preprint Server for Biology
|
July 14, 2025
Adropin protects against cardiac metabolic remodeling and dysfunction in HFpEF
Bellina A S Mushala, Michael W Stoner, Janet R Manning, et al.
Clinical Science (London, England : 1979)
|
June 11, 2026
Adropin protects against cardiac remodeling and metabolic dysfunction in a male mouse HFpEF model
Bellina A S Mushala, Michael W Stoner, Maryam Sharifi-Sanjani, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Biorxiv : the Preprint Server for Biology
|
June 6, 2025
GCN5L1 inhibits pyruvate dehydrogenase phosphorylation during cardiac ischemia-reperfusion injury
Paramesha Bugga, Michael W Stoner, Janet R Manning, et al.
Life Sciences
|
August 7, 2022
Empagliflozin prohibits high-fructose diet-induced cardiac dysfunction in rats via attenuation of mitochondria-driven oxidative stress
Paramesha Bugga, Soheb Anwar Mohammed, Md Jahangir Alam, et al.
Current Research in Physiology
|
February 7, 2022
Diet-induced obese mice are resistant to improvements in cardiac function resulting from short-term adropin treatment
Dharendra Thapa, Bingxian Xie, Bellina A S Mushala, et al.
The Biochemical Journal
|
April 29, 2024
Validation of GCN5L1/BLOC1S1/BLOS1 antibodies using knockout cells and tissue
Paramesha Bugga, Michael W Stoner, Janet R Manning, et al.
Scientific Reports
|
April 15, 2023
G-protein coupled receptor 19 (GPR19) knockout mice display sex-dependent metabolic dysfunction
Bellina A S Mushala, Bingxian Xie, Ian J Sipula, et al.
Biorxiv : the Preprint Server for Biology
|
November 19, 2025
Essential Role for Trf2 in Cardiac Development and Function
Ali Hakim Shoushtari, Aysenur Danis, Michael Wayne Stoner, et al.
FASEB Bioadvances
|
July 6, 2026
Essential Role for Telomeric Repeat-Binding Factor 2 in Cardiac Development and Function
Ali Hakim Shoushtari, Aysenure Danis, Michael Wayne Stoner, et al.
Physiological Reports
|
August 4, 2022
GCN5L1 impairs diastolic function in mice exposed to a high fat diet by restricting cardiac pyruvate oxidation
Dharendra Thapa, Paramesha Bugga, Bellina A S Mushala, et al.
Biorxiv : the Preprint Server for Biology
|
July 14, 2025
Adropin protects against cardiac metabolic remodeling and dysfunction in HFpEF
Bellina A S Mushala, Michael W Stoner, Janet R Manning, et al.
Clinical Science (London, England : 1979)
|
June 11, 2026
Adropin protects against cardiac remodeling and metabolic dysfunction in a male mouse HFpEF model
Bellina A S Mushala, Michael W Stoner, Maryam Sharifi-Sanjani, et al.
Page
of 3